Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Wyeth: News & Announcements Back to my archive search Start a new archive search 03/17/1999 American Home Products' Sonata ® (Zaleplon), First in a New Generation of Drugs to Treat Insomnia, Receives Marketing Authorization in Europe MADISON, N.J., March 17, 1999 -- American Home Products Corporation (NYSE: AHP - news) and its Wyeth-Ayerst Laboratories Division announced today that the European...
Wyeth: News & Announcements Back to my archive search Start a new archive search 05/17/1999 American Home Products Corporation Launches Sonata ® in Denmark and Sweden MADISON, N.J., May 17, 1999 -- American Home Products Corporation (NYSE: AHP) and its Wyeth Lederle Division today announced the launch of Sonata ® (zaleplon), a new treatment for insomnia, in Denmark and Sweden.
Wyeth: News & Announcements Back to my archive search Start a new archive search 06/01/1999 AMERICAN HOME PRODUCTS LAUNCHES SONATAA® IN GERMANY Madison, N.J., June 1, 1999 -- American Home Products Corporation (NYSE: AHP) and its Wyeth Lederle Division today announced the launch of SonataA® (zaleplon), a new treatment for insomnia, in Germany.A- Germany is the third European country where ...
Wyeth: News & Announcements Back to my archive search Start a new archive search 08/16/1999 American Home Products Announces FDA Approval for Sonata(R) (Zaleplon), A Breakthrough Approach to Treat Insomnia First New Product for Insomnia in Over Five Years Offers Flexible Administration MADISON, N.J., Aug.
Wyeth: News & Announcements Back to my archive search Start a new archive search 09/15/1999 AMERICAN HOME PRODUCTS ANNOUNCES SONATA ® (ZALEPLON) CLEARS FINAL REGULATORY HURDLE FOR U.S.
Wyeth: News & Announcements Back to my archive search Start a new archive search 10/18/1999 American Home Products Corporation Briefs Analysts on Research and Development Progress Madison, N.J., October 18, 1999 -- American Home Products Corporation (NYSE:AHP) held a meeting today for more than 300 securities analysts and investors to discuss AHP's global pharmaceutical business with an emphasis on the Company...
Wyeth: News & Announcements Back to my archive search Start a new archive search 02/07/2001 SONATA ® (zaleplon) C-IV NOW USED BY ASTRONAUTS IN SPACE - Sleep aid available to help shuttle astronauts in outer space overcome the difficulties of falling asleep - St.Sonata ® ...
Wyeth: News & Announcements Marketing for Sonata and Create Next Generation of Sonata Products Madison, New Jersey and Dublin, Ireland, December 20, 2001 -- American Home Products Corporation (NYSE: AHP) ("AHPa€), one of the world's largest research-based pharmaceutical and health care products companies, and Elan Corporation, plc (NYSE: ELN) ("Elana€), a leading...
Wyeth: News & Announcements American Home Products July 27, 1999 FDA Advisory Committee Concludes That American Home Products' Rapamune® (Sirolimus) is Safe and Effective for the Prevention of Kidney Transplant Rejection July 22, 1999 AMERICAN HOME PRODUCTS CORPORATION DECLARES COMMON STOCK DIVIDEND July 22, 1999 AMERICAN HOME PRODUCTS CORPORATION DECLARES PREFERRED STOCK DIVIDEND July 21, 1999 American...
Wyeth: News & Announcements FDA ACCEPTS AMERICAN HOME PRODUCTS CORPORATION'S PMA FOR RECOMBINANT PROTEIN TREATMENT FOR LONG-BONE FRACTURES February 08, 2001 NEW CONTRACEPTIVE HEALTH WEB SITE FOR LEADING 20 MICROGRAM BIRTH CONTROL PILL, ALESSE® February 07, 2001 SONATA ® (zaleplon) C-IV NOW USED BY ASTRONAUTS IN SPACE February 05, 2001 EUROPEAN COMMISSION GRANTS MARKETING AUTHORIZATION FOR...
Wyeth: Research & Development: Pipeline - Wyeth - Research & Development - Product Pipeline About-Wyeth -- Media-Room -- Corporate-Governance -- Wyeth-Divisions -- Products -- Wyeth-Worldwide -- Investor-Relations -- News-&-Announcements -- Research-&-Development -- Educational-Resources -- Careers-at-Wyeth Wyeth: Research & Development: Pipeline Wyeth: Research & Development: Pipeline Wyeth, biotechnology, Celera Genomics...
BioPortfolio Limited Insomnia - Wake-Up Call for a Sleepy Market TABLE OF CONTENTS EXECUTIVE SUMMARY 5 Introduction 5 Scope and coverage of the Brief 5 Key findings about the topic 6 DIESEASE OVERVIEW 9 Disease definition 9 Epidemiology 11 Economic consequences 15 Summary of patient potential 16 PHARMACOLOGICAL THERAPY 18 Benzodiazepines 18 Drugs used off-label 20 Unmet needs in insomnia 22 BRANDED...
Elan: News Article 30, 2003--Elan Corporation, plc (NYSE: ELN)-- Elan to receive a cash payment of approximately $650 million on closing including an estimated $40 million for inventory King to assume Elan's product related payments for Sonata of approximately $240 million Elan may receive up to an additional $60 million in net milestone payments relating to the development of enhanced...
Elan: News Article 30, 2003--Elan Corporation, plc (NYSE: ELN)-- Elan to receive a cash payment of approximately $650 million on closing including an estimated $40 million for inventory King to assume Elan's product related payments for Sonata of approximately $240 million Elan may receive up to an additional $60 million in net milestone payments relating to the development of enhanced...
http://www.fda.gov/cder/orange/appendix_a.txt 2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN...
2000 Warning Letters and Untitled Letters to Pharmaceutical Companies Food and Drug Administration • Center for Drug Evaluation and Research Compliance Activities Search Warning Letters and Untitled Letters to Pharmaceutical Companies 2000 These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information Office
Prescription and Over-the-Counter Drug Product List: 6/2003 >D> AP + WYETH AYERST 5,000 UNITS/VIAL N17055 001 JUN DISC >A> @ 5,000 UNITS/VIAL N17055 001 JUN DISC >D> AP + 10,000 UNITS/VIAL N17055 002 JUN DISC >A> @ 10,000 UNITS/VIAL N17055 002 JUN DISC GUANABENZ ACETATE TABLET; ORAL GUANABENZ ACETATE >D> AB WATSON LABS EQ 8MG BASE N74025 002 FEB 28, 1994 JUN CRLD >A> AB + EQ 8MG BASE N74025 002 FEB 28, 1994 JUN CRLD >D> WYTENSIN >D> AB WYETH...
author: AUTHOR
Report to the Nation: Drug Review Zaleplon (Sonata) is for the short-term treatment of insomnia in adults, including elderly patients
author: OLIVERN
Reference Listed Drug Labeling Approved in February 2001 letter label meropenem for injection 50-706 S-007 SUPRAX letter label cefixime oral suspension 50-622 S-014 VANCOCIN HCL letter label vancomycin hydrochloride capsules 50-606 S-014 ZYVOX letter label linezolid tablets linezolid injection linezolid for oral suspension 21-130 21-131 21-132 S-001 S-001 S-001 Feb 8 AVANDIA letter label rosiglitazone maleate tablets 21-071 S-006...
author: USERNAME
NMEs Approved in CY 1999 NMEs Approved in Calendar Year 1999 NDA Number Generic Name- Trade Name Dosage Form Applicant - --- Classification- Approval Date - - - - - - - 20-863 Cilostazol Pletal Tablet Otsuka Pharm 1S 01-15-1999 20-886 Alitretinoin Panretin Topical Gel Ligand Pharm 1-PV 02-02-1999 20-955 Sodium Ferric Gluconate Complex Ferrlicit Injectable R&D Labs 1P 02-18-1999 21-007 Amprenavir Agenerase...
author: Elaine Abraham
Reference Listed Drug Labeling Approved in May 2002 -- COUMADIN letter -- warfarin Na tablet 09-218 SLR 098 - COUMADIN letter - warfarin Na tablet 09-218 SLR 099 May 3 DURICEF letter label cefadroxil monohydrate capsule 50-528 SLR 018 DURICEF letter label cefadroxil monohydrate suspension 50-527 SLR 020 DURICEF letter label cefadroxil monohydrate tablet 50-512 SLR 044 PREVACID letter label lansoprazole tablet 21-281 SLR 002 --...
author: USERNAME
FDA Drug Approvals List May 2002 - Drug Approvals for May 2002 Definitions and Notes Original New Drug Applications Original Abbreviated Antibiotic Application # 065082 Approval Date: 31-MAY-02 Trade Name: CEFPODOXIME PROXETIL Dosage Form: GRANULE, FOR RECONSTITUTION Applicant: RANBAXY LABORATORIES LTD Active Ingredient(s): CEFPODOXIME PROXETIL OTC/RX Status: RX Original Application #: 021292 Approval Date: 31-MAY...
20859_Sonata.htm Sonata (Zaleplon) Capsules Food and Drug Administration • Center for Drug Evaluation and Research Approval Package [http://internet-dev/cder/templates/2ndrow-component.htm] [http://internet-dev/cder/templates/sidebar-component.htm] Sonata (Zaleplon) Capsules Company:- Wyeth-Ayerst Laboratories Application No.:- 020859 Approval Date:-8/13/99 - Approval Letter(s) & Final Printed Labeling (2.9 MB...
author: Paul Stauffer
